TRex Bio Inc. (TRXB) Stock Ticker
TRXB right now
Market factors today
Unlock the full TRXB picture
About TRex Bio Inc.
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
TRXB stock facts
| Ticker symbol | TRXB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| Market cap | $120.2M |
| CEO | Marion Johnston Erwin |
| Employees | 60 |
| Headquarters | South San Francisco, CA, US |
| IPO date | 2026-10-09 |
| Website | www.trex.bio |
What you can see for TRXB on Tickr
Live TRXB price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the TRXB report.
Rankings
FAQ
What is the ticker symbol for TRex Bio Inc.?
The ticker symbol for TRex Bio Inc. is TRXB, listed on the NASDAQ.
What is TRXB?
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San…